The risk of dementia could decrease with consistent use of smartphones and other technology among older adults, according to a new study from Baylor University.

Pharma advertisers have kicked off 2025 with a bang, with the top 10 spenders throwing almost 30% more money behind their TV ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Patients will lose access to cheaper versions of the blockbuster drugs after the agency shuts down the multibillion-dollar industry now that the drug shortage has ended. Also in the news: Eli Lilly's ...

Eli Lilly’s new oral weight loss pill, orforglipron, successfully passed late-stage trials, showing positive results for ...

As an affordability crisis grows in pricey New England, the rising cost of prescription drugs is squeezing patients, health ...

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and protection from dementia may soon be added to the list.

The Department of Commerce launched an investigation on April 1 into the national security impacts of importing drugs and ...